Projects per year
Abstract
Epstein-Barr virus (EBV), a B-lymphotropic herpesvirus widespread in the human population and normally contained as an asymptomatic infection by T cell surveillance, nevertheless causes infectious mononucleosis and is strongly linked to several types of human cancer. Here we describe new findings on the range of cellular immune responses induced by EBV infection, on viral strategies to evade those responses and on the links between HLA gene loci and EBV-induced disease. The success of adoptive T cell therapy for EBV-driven post-transplant lymphoproliferative disease is stimulating efforts to target other EBV-associated tumours by immunotherapeutic means, and has reawakened interest in the ultimate intervention strategy, a prophylactic EBV vaccine.
Original language | English |
---|---|
Pages (from-to) | 258-64 |
Number of pages | 7 |
Journal | Current Opinion in Immunology |
Volume | 23 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Apr 2011 |
Fingerprint
Dive into the research topics of 'Immune defence against EBV and EBV-associated disease.'. Together they form a unique fingerprint.Projects
- 1 Finished
-
Cellular Immunity to Herpesvirus Infections: Studies with Epstein-Barr Virus (EBV) and Human Cytomegalovirus (CMV)
Rickinson, A., Moss, P. & Rowe, M.
1/09/10 → 31/08/15
Project: Research Councils